Header Logo

HEATHER MOORE

TitleAssociate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
Address6701 FANNIN
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Bennetts JD, Williams TD, Beavers CJ, Moore HN, Robson C, Warner T, Dent S, Sverdlov AL, Ngo DTM. The cardio-oncology multidisciplinary team: beyond the basics. Cardiooncology. 2025 Jul 26; 11(1):69. PMID: 40713756; PMCID: PMC12297693.
      Citations:    
    2. Mart?n M, Lim E, Chavez-MacGregor M, Bardia A, Wu J, Zhang Q, Nowecki Z, Cruz FM, Safin R, Kim SB, Schem C, Montero AJ, Khan S, Bandyopadhyay R, Moore HM, Shivhare M, Patre M, Martinalbo J, Roncoroni L, P?rez-Moreno PD, Sohn J, acelERA Breast Cancer Study Investigators. Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study. J Clin Oncol. 2024 Jun 20; 42(18):2149-2160. PMID: 38537155; PMCID: PMC11185917.
      Citations:    
    3. Kamboj M, Bohlke K, Baptiste DM, Dunleavy K, Fueger A, Jones L, Kelkar AH, Law LY, LeFebvre KB, Ljungman P, Miller ED, Meyer LA, Moore HN, Soares HP, Taplitz RA, Woldetsadik ES, Kohn EC. Vaccination of Adults With Cancer: ASCO Guideline. J Clin Oncol. 2024 May 10; 42(14):1699-1721. PMID: 38498792; PMCID: PMC11095883.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    4. Jhaveri KL, Bellet M, Turner NC, Loi S, Bardia A, Boni V, Sohn J, Neilan TG, Villanueva-V?zquez R, Kabos P, Garc?a-Est?vez L, L?pez-Miranda E, P?rez-Fidalgo JA, P?rez-Garc?a JM, Yu J, Fredrickson J, Moore HM, Chang CW, Bond JW, Eng-Wong J, Gates MR, Lim E. Phase Ia/b Study of Giredestrant ? Palbociclib and ? Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor-Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer. Clin Cancer Res. 2024 02 16; 30(4):754-766. PMID: 37921755; PMCID: PMC10870118.
      Citations:    
    5. Gallagher EJ, Moore H, Lacouture ME, Dent SF, Farooki A, Goncalves MD, Isaacs C, Johnston A, Juric D, Quandt Z, Spring L, Berman B, Decker M, Hortobagyi GN, Kaffenberger BH, Kwong BY, Pluard T, Rao R, Schwartzberg L, Broder MS. Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique. NPJ Breast Cancer. 2024 Jan 31; 10(1):12. PMID: 38297009; PMCID: PMC10831089.
      Citations:    
    6. Hurvitz SA, Bardia A, Quiroga V, Park YH, Blancas I, Alonso-Romero JL, Vasiliev A, Adamchuk H, Salgado M, Yardley DA, Berzoy O, Zamora-Au??n P, Chan D, Spera G, Xue C, Ferreira E, Badovinac Crnjevic T, P?rez-Moreno PD, L?pez-Valverde V, Steinseifer J, Fernando TM, Moore HM, Fasching PA, coopERA Breast Cancer study group. Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study. Lancet Oncol. 2023 09; 24(9):1029-1041. PMID: 37657462.
      Citations:    
    7. Bardia A, Mayer I, Winer E, Linden HM, Ma CX, Parker BA, Bellet M, Arteaga CL, Cheeti S, Gates M, Chang CW, Fredrickson J, Spoerke JM, Moore HM, Giltnane J, Friedman LS, Chow Maneval E, Chan I, Jhaveri K. The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR?+?/HER2?-) advanced/metastatic breast cancer. Breast Cancer Res Treat. 2023 Jan; 197(2):319-331. PMID: 36401732; PMCID: PMC9823088.
      Citations:    
    8. . Associate Editors Julie Stein O'Brien Brent A. Mothner Heather C. Moore Christian M Niedzwecki. Rudolph's Pediatrics 23rd Edition Self-Assessment and Board Review. 2022.
    9. Tomek S, Moore H, Hooper LM, Bolland AC, Robinson CD, Bolland JM. A longitudinal study of the impact of school delinquency on self-worth development among Black American adolescents. J Community Psychol. 2020 09; 48(7):2391-2409. PMID: 32789906.
      Citations:    
    10. Israelsson E, Chaussabel D, Fischer RSB, Moore HC, Robinson DA, Dunkle JW, Essigmann HT, Record S, Brown EL. Characterization of peripheral blood mononuclear cells gene expression profiles of pediatric Staphylococcus aureus persistent and non-carriers using a targeted assay. Microbes Infect. 2020 Nov - Dec; 22(10):540-549. PMID: 32758644; PMCID: PMC7722038.
      Citations: 1     Fields:    Translation:HumansCells
    11. Maltreatment of Children and Youth with Special Healthcare Needs. 2019; 337-354.
    12. Majhail NS, Murphy E, Laud P, Preussler JM, Denzen EM, Abetti B, Adams A, Besser R, Burns LJ, Cerny J, Drexler R, Hahn T, Idossa L, Jahagirdar B, Kamani N, Loren A, Mattila D, McGuirk J, Moore H, Reynolds J, Saber W, Salazar L, Schatz B, Stiff P, Wingard JR, Syrjala KL, Baker KS. Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors. Haematologica. 2019 05; 104(5):1084-1092. PMID: 30514795; PMCID: PMC6518896.
      Citations:    
    13. . Rudolph's Pediatrics - Mark Kline, MD, Editor in Chief. Managing Children with Intellectual and Developmental Disabilities in Rudolph's Pediatrics, 23rd Edition. 2018; (23).
    14. Whiteaker JR, Zhao L, Ivey RG, Sanchez-Bonilla M, Moore HD, Schoenherr RM, Yan P, Lin C, Shimamura A, Paulovich AG. Targeted mass spectrometry enables robust quantification of FANCD2 mono-ubiquitination in response to DNA damage. DNA Repair (Amst). 2018 05; 65:47-53. PMID: 29605812; PMCID: PMC5911425.
      Citations:    
    15. Whiteaker JR, Zhao L, Saul R, Kaczmarczyk JA, Schoenherr RM, Moore HD, Jones-Weinert C, Ivey RG, Lin C, Hiltke T, Reding KW, Whiteley G, Wang P, Paulovich AG. A Multiplexed Mass Spectrometry-Based Assay for Robust Quantification of Phosphosignaling in Response to DNA Damage. Radiat Res. 2018 05; 189(5):505-518. PMID: 29474155; PMCID: PMC5939939.
      Citations:    
    16. . Threats to the Medically Complex Child. APSAC Advisor. 2017; 31-38.
    17. Thrasher J, Baker J, Ventre KM, Martin SE, Dawson J, Cox R, Moore HM, Brethouwer S, Sables-Baus S, Baker CD. Hospital to Home: A Quality Improvement Initiative to Implement High-fidelity Simulation Training for Caregivers of Children Requiring Long-term Mechanical Ventilation. J Pediatr Nurs. 2018 Jan - Feb; 38:114-121. PMID: 28943140; PMCID: PMC6456906.
      Citations:    
    MOORE's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (81)
    Explore
    _
    Co-Authors (1)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _